Lupus is a condition often shrouded in mystery. Presenting with a huge range of symptoms, it’s tricky to diagnose, tough to ...

An infectious diseases expert has raised eyebrows after she successfully treated her own breast cancer by injecting her ...

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

These disorders often involve disruptions in immune tolerance, leading to autoimmunity ... Effect of intravenous IgG therapy on natural killer cell function related to Fc gamma receptor gene ...

To better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny ...

Research and development expenses increased to $17.0 million for the three months ended September 30, 2024 from $15.4 million for the three months ended September 30, 2023 primarily due to ...

Researchers at City of Hope now understand why taking an investigational white button mushroom supplement shows promise in ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...

Median overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...